A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
LeukoVantage®, Acute Myeloid Leukemia (AML)
Test Code36787
CPT Codes
81450
Includes
ASXL1, ATM, BCOR, BCORL1, CBL, CDKN2B, CEBPA, CREBP(ATF2), CSF3R, DDX41, DNMT3A, ETV6, EZH2, FLT3, GATA1, GATA2, IDH1, IDH2, IKZF1, JAK2, KDM6A, KIT, KRAS, MLL (PTD only), MPL, NF1, NPM1, NRAS, PHF6, PTEN, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, STAG2, STK11, TET2, TP53, U2AF1, WT1, ZRSR2 genes
Preferred Specimen
5 mL whole blood or bone marrow collected in an EDTA (lavender-top) tube
Minimum Volume
2 mL whole blood or bone marrow • 20 uL of 10 ng/uL DNA
Other Acceptable Specimens
Whole blood or bone marrow collected in: Sodium heparin (green-top) tube • 50 uL of 10 ng/uL extracted DNA in microcentrifuge tube
Instructions
Requisition form and Pathology/Flow Cytometry Reports are required. In addition, only accept extracted DNA when extraction or isolation is performed in an appropriately qualified laboratory such as a CLIA certified laboratory or a laboratory meeting equivalent requirements as determined by the CAP and/or CMS.
Transport Temperature
Room temperature
Specimen Stability
Whole blood or bone marrow (EDTA)
Room temperature: 14 days
Refrigerated: 14 days
Frozen: Unacceptable
Whole blood or bone marrow (Sodium heparin)
Room temperature: 7 days
Refrigerated: 7 days
Frozen: Unacceptable
Extracted DNA
Room temperature: 30 days
Refrigerated: 2 years
Frozen: Indefinite
Room temperature: 14 days
Refrigerated: 14 days
Frozen: Unacceptable
Whole blood or bone marrow (Sodium heparin)
Room temperature: 7 days
Refrigerated: 7 days
Frozen: Unacceptable
Extracted DNA
Room temperature: 30 days
Refrigerated: 2 years
Frozen: Indefinite
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Frozen • Clotted
Methodology
Next Generation Sequencing • Long Range Polymerase Chain Reaction
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics Nichols Institute. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Tuesday, Thursday Morning Report available: 11 Days
Reference Range
See Laboratory Report
Clinical Significance
This test is designed to aid in diagnosis and/or treatment strategy for patients with AML.
Performing Laboratory
Quest Diagnostics Nichols Institute-San Juan Capistrano, CA |
33608 Ortega Highway |
San Juan Capistrano, CA 92675-2042 |